3/21/2013 10:26:22 AM
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) commends Virginia Governor Bob McDonnell for signing legislation today designed to address the regulatory issues related to the interchangeability of biological medicines. The policies outlined in identical House Bill 1422 and Senate Bill 1285 align with all five of BIO’s principles on biologic substitution. BIO and VABIO furthermore commend the actions of the Virginia General Assembly for unanimously passing these bills out of session on February 19, 2013.
comments powered by